Skip to main content

2 Result(s)

within Zhengkang Luo Remove this filter

and

  1. Article

    Open Access

    Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetes

    Much focus of immunotherapy for type 1 diabetes (T1D) has been devoted on selectively boosting regulatory T (Treg) cells using low dose IL-2 due to their constitutive expression of IL-2Rα, CD25. However, sever...

    Zhengkang Luo, Mariela Mejia-Cordova, Nour Hamze, Elin Berggren, Saloni Chopra… in Endocrine (2024)

    Download PDF (2263 KB) View Article

  2. Article

    Open Access

    The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors

    The tamoxifen-responsive conditional Cdh5-CreERT2 is commonly used for endothelial cell specific conditional deletion of loxP-flanked gene sequences. To address the role of endothelial cell Shb gene for B16F10 me...

    Qi He, **ujuan Li, Kailash Singh, Zhengkang Luo… in Scientific Reports (2019)

    Download PDF (1816 KB) View Article